From Simple English Wikipedia, the free encyclopedia

Covaxin (codenamed as BBV152) is an inactivated virus-based COVID-19 vaccine created by Bharat Biotech.

As of October 2021, 110.6 million people in India have received Covaxin.[1] On 3 November 2021, the World Health Organization (WHO) approved the vaccine for emergency use.[2][3]

References[change | change source]

  1. "Cowin statistics". Cowin. Ministry of health and family welfare India. 23 October 2021.{{cite web}}: CS1 maint: url-status (link)
  2. "India's first homegrown COVID-19 shot wins WHO emergency use listing". Reuters. 3 November 2021.
  3. "WHO issues emergency use listing for eighth COVID-19 vaccine". World Health Organization (WHO) (Press release). Retrieved 3 November 2021.